VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $419,090,000 | +46.2% | 18,033,149 | +0.1% | 3.79% | +32.0% |
| Q1 2018 | $286,744,000 | -23.4% | 18,011,537 | +0.0% | 2.88% | -24.1% |
| Q4 2017 | $374,248,000 | +45.0% | 18,010,027 | 0.0% | 3.79% | +46.4% |
| Q3 2017 | $258,084,000 | -17.1% | 18,010,027 | +0.1% | 2.59% | -7.0% |
| Q2 2017 | $311,352,000 | +56.8% | 17,997,224 | 0.0% | 2.78% | +67.3% |
| Q1 2017 | $198,509,000 | -8.8% | 17,997,224 | +20.0% | 1.66% | -7.0% |
| Q4 2016 | $217,717,000 | -40.9% | 14,994,261 | 0.0% | 1.79% | -44.2% |
| Q3 2016 | $368,109,000 | +21.9% | 14,994,261 | 0.0% | 3.20% | +16.9% |
| Q2 2016 | $301,984,000 | -23.4% | 14,994,261 | 0.0% | 2.74% | -30.4% |
| Q1 2016 | $394,349,000 | -74.1% | 14,994,261 | 0.0% | 3.94% | -62.7% |
| Q4 2015 | $1,524,167,000 | -43.0% | 14,994,261 | 0.0% | 10.55% | -32.2% |
| Q3 2015 | $2,674,676,000 | -19.7% | 14,994,261 | 0.0% | 15.55% | -11.3% |
| Q2 2015 | $3,330,975,000 | -13.5% | 14,994,261 | -22.6% | 17.54% | -17.6% |
| Q1 2015 | $3,850,026,000 | +38.8% | 19,383,877 | 0.0% | 21.28% | +22.4% |
| Q4 2014 | $2,774,027,000 | +11.7% | 19,383,877 | +2.4% | 17.38% | +4.5% |
| Q3 2014 | $2,482,813,000 | +4.0% | 18,923,877 | 0.0% | 16.64% | -5.7% |
| Q2 2014 | $2,386,679,000 | -4.3% | 18,923,877 | 0.0% | 17.64% | -6.3% |
| Q1 2014 | $2,494,735,000 | +12.3% | 18,923,877 | 0.0% | 18.84% | +2.5% |
| Q4 2013 | $2,221,663,000 | +12.5% | 18,923,877 | 0.0% | 18.37% | +3.1% |
| Q3 2013 | $1,974,328,000 | +21.2% | 18,923,877 | 0.0% | 17.82% | +6.5% |
| Q2 2013 | $1,628,967,000 | – | 18,923,877 | – | 16.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |